AR043071A1 - Uso de macrolidos para el tratamiento del cancer y degeneracion macular y una composicion farmaceutica - Google Patents
Uso de macrolidos para el tratamiento del cancer y degeneracion macular y una composicion farmaceuticaInfo
- Publication number
- AR043071A1 AR043071A1 ARP980105434A ARP980105434A AR043071A1 AR 043071 A1 AR043071 A1 AR 043071A1 AR P980105434 A ARP980105434 A AR P980105434A AR P980105434 A ARP980105434 A AR P980105434A AR 043071 A1 AR043071 A1 AR 043071A1
- Authority
- AR
- Argentina
- Prior art keywords
- macrolides
- treatment
- pharmaceutical composition
- macular degeneration
- cancer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US96147397A | 1997-10-31 | 1997-10-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR043071A1 true AR043071A1 (es) | 2005-07-20 |
Family
ID=25504514
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980105434A AR043071A1 (es) | 1997-10-31 | 1998-10-29 | Uso de macrolidos para el tratamiento del cancer y degeneracion macular y una composicion farmaceutica |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1027060A2 (pt) |
| JP (1) | JP2001521891A (pt) |
| KR (1) | KR20010031577A (pt) |
| CN (1) | CN1278178A (pt) |
| AR (1) | AR043071A1 (pt) |
| AU (1) | AU1206799A (pt) |
| BG (1) | BG104436A (pt) |
| BR (1) | BR9813318A (pt) |
| CA (1) | CA2307850A1 (pt) |
| HU (1) | HUP0100012A3 (pt) |
| IL (1) | IL135518A0 (pt) |
| NO (1) | NO20002189L (pt) |
| PL (1) | PL340604A1 (pt) |
| SK (1) | SK6172000A3 (pt) |
| TR (1) | TR200001147T2 (pt) |
| WO (1) | WO1999022722A2 (pt) |
| ZA (1) | ZA989885B (pt) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4858801A (en) | 2000-04-13 | 2001-10-30 | Biotica Tech Ltd | Hybrid glycosylated products and their production and use |
| DK1539157T3 (da) | 2002-09-18 | 2013-10-07 | Univ Pennsylvania | Fremgangsmåde til hæmning af choroidal neovaskularisering |
| TW200420573A (en) | 2002-09-26 | 2004-10-16 | Rib X Pharmaceuticals Inc | Bifunctional heterocyclic compounds and methods of making and using same |
| US7354574B2 (en) | 2002-11-07 | 2008-04-08 | Advanced Ocular Systems Limited | Treatment of ocular disease |
| JP4719671B2 (ja) | 2003-03-28 | 2011-07-06 | コーネル・リサーチ・ファンデーション・インコーポレイテッド | ミグラスタチンアナログ組成物およびその使用 |
| US7083802B2 (en) | 2003-07-31 | 2006-08-01 | Advanced Ocular Systems Limited | Treatment of ocular disease |
| US7087237B2 (en) * | 2003-09-19 | 2006-08-08 | Advanced Ocular Systems Limited | Ocular solutions |
| US7083803B2 (en) | 2003-09-19 | 2006-08-01 | Advanced Ocular Systems Limited | Ocular solutions |
| US8202843B2 (en) * | 2004-02-27 | 2012-06-19 | Rib-X Pharmaceuticals, Inc. | Macrocyclic compounds and methods of making and using the same |
| CN1950388A (zh) * | 2004-02-27 | 2007-04-18 | 瑞伯-X医药品有限公司 | 大环化合物以及其制作和使用方法 |
| WO2006001967A2 (en) | 2004-05-25 | 2006-01-05 | Sloan-Kettering Institute For Cancer Research | Migrastatin analogs in the treatment of cancer |
| CA2582766C (en) | 2004-09-23 | 2014-07-22 | Sloan-Kettering Institute For Cancer Research | Isomigrastatin analogs in the treatment of cancer |
| BRPI0608152A2 (pt) | 2005-02-09 | 2009-11-10 | Macusight Inc | formulações para tratamento ocular |
| PL1904056T3 (pl) | 2005-07-18 | 2009-09-30 | Minu Llc | Zastosowanie makrolidu do przywracania czucia rogówkowego |
| US8470985B2 (en) | 2005-08-24 | 2013-06-25 | Rib-X Pharmaceuticals, Inc. | Triazole compounds and methods of making and using the same |
| US8278281B2 (en) | 2005-08-24 | 2012-10-02 | Rib-X Pharmaceuticals, Inc. | Triazole compounds and methods of making and using the same |
| AU2007212271B2 (en) | 2006-02-09 | 2012-11-01 | Santen Pharmaceutical Co., Ltd. | Stable formulations, and methods of their preparation and use |
| JP5506378B2 (ja) | 2006-03-23 | 2014-05-28 | 参天製薬株式会社 | 血管透過性に関連する疾患または病気のための製剤および方法 |
| CN106317146B (zh) * | 2015-06-18 | 2019-06-21 | 沈阳药科大学 | 双环克拉霉素衍生物及其作为肿瘤细胞增值抑制剂的用途 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU6461090A (en) * | 1989-10-30 | 1991-05-02 | Abbott Laboratories | Injectable formulation for lipophilic drugs |
| US5498424A (en) * | 1994-11-30 | 1996-03-12 | Klein; Ira | Method of treating obesity |
-
1998
- 1998-10-29 ZA ZA989885A patent/ZA989885B/xx unknown
- 1998-10-29 AR ARP980105434A patent/AR043071A1/es unknown
- 1998-10-30 IL IL13551898A patent/IL135518A0/xx unknown
- 1998-10-30 TR TR2000/01147T patent/TR200001147T2/xx unknown
- 1998-10-30 KR KR1020007004625A patent/KR20010031577A/ko not_active Application Discontinuation
- 1998-10-30 AU AU12067/99A patent/AU1206799A/en not_active Abandoned
- 1998-10-30 HU HU0100012A patent/HUP0100012A3/hu unknown
- 1998-10-30 CA CA002307850A patent/CA2307850A1/en not_active Abandoned
- 1998-10-30 WO PCT/US1998/023043 patent/WO1999022722A2/en not_active Application Discontinuation
- 1998-10-30 BR BR9813318-7A patent/BR9813318A/pt not_active Application Discontinuation
- 1998-10-30 PL PL98340604A patent/PL340604A1/xx unknown
- 1998-10-30 SK SK617-2000A patent/SK6172000A3/sk unknown
- 1998-10-30 JP JP2000518656A patent/JP2001521891A/ja not_active Withdrawn
- 1998-10-30 EP EP98955206A patent/EP1027060A2/en not_active Withdrawn
- 1998-10-30 CN CN98810825A patent/CN1278178A/zh active Pending
-
2000
- 2000-04-27 NO NO20002189A patent/NO20002189L/no unknown
- 2000-05-15 BG BG104436A patent/BG104436A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO20002189D0 (no) | 2000-04-27 |
| JP2001521891A (ja) | 2001-11-13 |
| ZA989885B (en) | 1999-05-05 |
| NO20002189L (no) | 2000-06-28 |
| AU1206799A (en) | 1999-05-24 |
| WO1999022722A2 (en) | 1999-05-14 |
| SK6172000A3 (en) | 2001-03-12 |
| CA2307850A1 (en) | 1999-05-14 |
| HUP0100012A2 (hu) | 2001-05-28 |
| EP1027060A2 (en) | 2000-08-16 |
| WO1999022722A3 (en) | 1999-08-05 |
| KR20010031577A (ko) | 2001-04-16 |
| BR9813318A (pt) | 2000-08-22 |
| IL135518A0 (en) | 2001-05-20 |
| HUP0100012A3 (en) | 2003-07-28 |
| CN1278178A (zh) | 2000-12-27 |
| PL340604A1 (en) | 2001-02-12 |
| BG104436A (en) | 2000-12-29 |
| TR200001147T2 (tr) | 2000-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR043071A1 (es) | Uso de macrolidos para el tratamiento del cancer y degeneracion macular y una composicion farmaceutica | |
| SE8504945L (sv) | Farmaceutiska kompositioner innehallande antracyklinglykosider | |
| GEP20043324B (en) | Purine Derivatives | |
| PT1292594E (pt) | Derivados de quinazolina para o tratamento de tumores | |
| ES2159591T3 (es) | Composicion de liberacion controlada. | |
| AR023423A1 (es) | Derivados de adamantano, procedimientos para su preparacion, composicion farmaceutica, procedimiento para la preparacion de la composicion farmaceutica, yuso de dichos derivados para la manufactura de medicamentos | |
| CY1107838T1 (el) | Παραγωγα αδαμαντανιου για τη θεραπεια φλεγμονωδων, ανοσολογικων και καρδιαγγειακων ασθενειων | |
| UY26635A1 (es) | Métodos sinérgicos y composiciones para el tratamiento del cáncer | |
| EE200000320A (et) | Uudsed ühendid | |
| SE9704544D0 (sv) | Novel compounds | |
| CY1109364T1 (el) | Ενας συνδυασμος που περιλαμβανει κομβρεταστατινη και αντικαρκινικους παραγοντες | |
| BR0112591A (pt) | Derivados de acridina e sua aplicação como medicamento | |
| UA50719C2 (uk) | Проліки для терапії пухлин і запальних захворювань | |
| AR011133A1 (es) | MICROGRÁNULOS DE LIBERACIoN CONTROLADA QUE CONTIENEN CISPLATINO , PROCEDIMIENTO DE SU PREPARACIoN, COMPOSICIoN FARMACÉUTICA Y UTILIZACIoN EN LA FABRICACIoN DE UN MEDICAMENTO POLIQUIMIOTERAPIA O EN ASOCIACIoN CON UNA RADIOTERAPIA. | |
| TR199900336T2 (xx) | EAA antagonistleri olarak tetrahidrokinolin t�revleri. | |
| BRPI0008228B8 (pt) | composição farmacêutica contendo n-benzoil estaurosporina e agentes solubilizantes | |
| PT1212312E (pt) | Novos derivados de flavonas xantonas e cumarinas | |
| ATE146361T1 (de) | Therapeutische mittel für die behandlungder resistenz gegen arzneimittel bei krebs | |
| AR017440A1 (es) | Uso de un inhibidor de fpt y de un agente antineoplasico en la preparacion de un medicamento para terapia de combinacion | |
| AR025060A1 (es) | Formulaciones farmaceuticas en capsulas de hidroxipropilmetilcelulosa | |
| IL165086A (en) | Pyridyl cyanoguanidines, pharmaceutical compositions comprising them and uses thereof for the preparation of medicaments | |
| TR200200473T2 (tr) | Rar selektif retinoid agonistleri. | |
| AR014640A1 (es) | UNA COMPOSICíoN FARMACÉUTICA INHIBIDORA DE LA DISEMINACIoN METASTÁSICA DURANTE LA CIRUGíA DE UN TUMOR CANCEROSO, UN PROCEDIMENTO DE PREPARACIoN Y UN KIT PARA UNA FORMULACIoN INYECTABLE. | |
| AR034142A1 (es) | Una composicion farmaceutica, metodo para fabricar un medicamento en base a dicha composicion y uso de la composicion | |
| DK0773782T3 (da) | Terpenderivater (sarcodictyiner) anvendelse som antitumormidler |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |